Frank Torti Named Acting FDA Commissioner

January 15, 2009

On January 20, FDA Commissioner Andrew von Eschenback, MD, will step down as commissioner and Frank Torti, MD, will take over as acting commissioner.

On January 20, FDA Commissioner Andrew von Eschenback, MD, will step down as commissioner and Frank Torti, MD, will take over as acting commissioner.

Torti has been the principal deputy commissioner and chief scientist at the FDA since May 2008.

Torti received his BA and MA degrees from Johns Hopkins University, his MD from Harvard Medical School, and his MPH from the Harvard School of Public Health, where he trained in cancer epidemiology and nutrition. He joined Wake Forest University School of Medicine in 1993 as the Charles L. Spurr professor of Medicine, director of the Comprehensive Cancer Center, and chair of the Department of Cancer Biology.